New tests to detect antiphospholipid antibodies: Antiprothrombin (aPT) and anti-phosphatidylserine/prothrombin (aPS/PT) antibodies

Current Rheumatology Reports

Volumn 16, Issue 5, 2014, Pages

  Sciascia, Savino ^a,b   Khamashta, Munther A ^a   Bertolaccini, Maria Laura ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

Anti phosphatidylserine; Antiphospholipid antibodies; Antiphospholipid syndrome; Antiprothrombin; Stroke; Thrombosis .Venous thrombosis

Indexed keywords

LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY; PROTHROMBIN ANTIBODY; PROTHROMBIN COMPLEX; AUTOANTIBODY; PHOSPHATIDYLSERINE; PROTHROMBIN;

ANTIBODY DETECTION; ANTICOAGULATION; ANTIGEN ANTIBODY COMPLEX; ANTIGEN RECOGNITION; ANTIPHOSPHOLIPID SYNDROME; ARTERY THROMBOSIS; ARTICLE; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GLOBAL ANTIPHOSPHOLIPID SYNDROME SCORE; HUMAN; SCORING SYSTEM; SPONTANEOUS ABORTION; VEIN THROMBOSIS; IMMUNOLOGY;

ANTIBODIES, ANTIPHOSPHOLIPID; AUTOANTIBODIES; HUMANS; PHOSPHATIDYLSERINES; PROTHROMBIN;

EID: 84895092933     PISSN: 15233774     EISSN: 15346307     Source Type: Journal    
DOI: 10.1007/s11926-014-0415-x     Document Type: Article

References (49)

1. Ruiz-Irastorza G, Crowther M, Branch W, Khamashta MA. Antiphospholipid syndrome. Lancet. 2010;376(9751):1498-509.
2. Giannakopoulos B, Krilis SA. The pathogenesis of the antiphospholipid syndrome. N Engl J Med. 2013;368(11):1033-44.
3. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). JTH. 2006;4(2):295-306.
4. Bertolaccini ML. Antibodies to prothrombin. Lupus. 2012;21(7): 729-31.
5. Bertolaccini ML, Gomez S, Pareja JF, Theodoridou A, Sanna G, Hughes GR, et al. Antiphospholipid antibody tests: spreading the net. Ann Rheum Dis. 2005;64(11):1639-43. (Pubitemid 41532050)
6. Bertolaccini ML, Amengual O, Atsumi T, Binder WL, de Laat B, Forastiero R, et al. 'Non-criteria' aPL tests: report of a task force and preconference workshop at the 13th International Congress on Antiphospholipid Antibodies, Galveston, TX, USA, April 2010. Lupus. 2011;20(2):191-205.
7. Mann KG, Nesheim ME, Church WR, Haley P, Krishnaswamy S. Surface-dependent reactions of the vitamin K-dependent enzyme complexes. Blood. 1990;76(1):1-16. (Pubitemid 20220784)
8. Loeliger A. Prothrombin as a co-factor of the circulating anticoagulant in systemic lupus erythematosus? Thromb Diath Haemorrh. 1959;3:237-56.
9. Bertolaccini ML, Atsumi T, Koike T, Hughes GR, KhamashtaMA. Antiprothrombin antibodies detected in two different assay systems. Prevalence and clinical significance in systemic lupus erythematosus. Thromb Haemost. 2005;93(2):289-97. (Pubitemid 40253734)
10. Atsumi T, Ieko M, Bertolaccini ML, Ichikawa K, Tsutsumi A, Matsuura E, et al. Association of autoantibodies against the phosphatidylserine-prothrombin complex with manifestations of the antiphospholipid syndrome and with the presence of lupus anticoagulant. Arthritis Rheum. 2000;43(9):1982-93.
11. Galli M, Beretta G, Daldossi M, Bevers EM, Barbui T. Different anticoagulant and immunological properties of anti-prothrombin antibodies in patients with antiphospholipid antibodies. Thromb Haemost. 1997;77(3):486-91. (Pubitemid 27121014)
12. Bevers EM, Galli M, Barbui T, Comfurius P, Zwaal RF. Lupus anticoagulant IgG's (LA) are not directed to phospholipids only, but to a complex of lipid-bound human prothrombin. Thromb Haemost. 1991;66(6):629-32.
13. Rao LV, Hoang AD, Rapaport SI. Differences in the interactions of lupus anticoagulant IgG with human prothrombin and bovine prothrombin. Thromb Haemost. 1995;73(4):668-74.
14. Wu JR, Lentz BR. Phospholipid-specific conformational changes in human prothrombin upon binding to procoagulant acidic lipid membranes. Thromb Haemost. 1994;71:596-604. (Pubitemid 24132958)
15. Rao LV, Hoang AD, Rapaport SI. Mechanism and effects of the binding of lupus anticoagulant IgG and prothrombin to surface phospholipid. Blood. 1996;88(11):4173-82. (Pubitemid 26399163)
16. Akimoto T, Akama T, Kono I, Sumida T. Relationship between clinical features and binding domains of anti-prothrombin autoantibodies in patients with systemic lupus erythematosus and antiphospholipid syndrome. Lupus. 1999;8(9):761-6.
17. Malia RG, Brooksfield C, Bulman L, Greaves M. Prothrombin fragment 1-2: the epitope for antiphospholipid antibody expression. Thromb Haemost. 1997;171:689.
18. Bajaj SP, Rapaport SI, Fierer DS, Herbst KD, Schwartz DB. A mechanism for the hypoprothrombinemia of the acquired hypoprothrombinemia-lupus anticoagulant syndrome. Blood. 1983;61(4):684-92. (Pubitemid 13115368)
19. Rapaport SI, Ames SB, Duvall BJ. A plasma coagulation defect in systemic lupus erythematosus arising from hypoprothrombinemia combined with antiprothrombinase activity. Blood. 1960;15:212-27.
20. Erkan D, Bateman H, Lockshin MD. Lupus anticoagulanthypoprothrombinemia syndrome associated with systemic lupus erythematosus: report of 2 cases and review of literature. Lupus. 1999;8:560-4. (Pubitemid 29452571)
21. Edson JR, Vogt JM, Hasegawa DK. Abnormal prothrombin crossed- immunoelectrophoresis in patients with lupus inhibitors. Blood. 1984;64(4):807-16. (Pubitemid 14003601)
22. Fleck RA, Rapaport SI, Rao LV. Anti-prothrombin antibodies and the lupus anticoagulant. Blood. 1988;72(2):512-9.
23. Pengo V, Denas G, Bison E, Banzato A, Jose SP, Gresele P, et al. Prevalence and significance of anti-prothrombin (aPT) antibodies in patients with Lupus Anticoagulant (LA). Thromb Res. 2010;126(2):150-3.
24. Horbach DA, van Oort E, Derksen RH, de Groot PG. The contribution of anti-prothrombin-antibodies to lupus anticoagulant activity-discrimination between functional and non-functional antiprothrombin-antibodies. Thromb Haemost. 1998;79(4):790-5. (Pubitemid 28163856)
25. Atsumi T, Amengual O, Yasuda S, Koike T. Antiprothrombin antibodies-are they worth assaying? Thromb Res. 2004;114(5-6):533-8. (Pubitemid 39422588)
26. Pengo V, Biasiolo A, Brocco T, Tonetto S, Ruffatti A. Autoantibodies to phospholipid-binding plasma proteins in patients with thrombosis and phospholipid-reactive antibodies. Thromb Haemost. 1996;75(5):721-4. (Pubitemid 26181539)
27. Roubey RA. Autoantibodies to phospholipid-binding plasma proteins: a new view of lupus anticoagulants and other "antiphospholipid" autoantibodies. Blood. 1994;84(9):2854-67.
28. BertolacciniML, Atsumi T, KhamashtaMA, Amengual O, Hughes GR. Autoantibodies to human prothrombin and clinical manifestations in 207 patients with systemic lupus erythematosus. J Rheumatol. 1998;25(6):1104-8. (Pubitemid 28350883)
29. Vaarala O, Puurunen M, Manttari M, Manninen V, Aho K, Palosuo T. Antibodies to prothrombin imply a risk of myocardial infarction in middle-aged men. Thromb Haemost. 1996;75(3):456-9. (Pubitemid 26099711)
30. Hoxha A, Ruffatti A, Pittoni M, Bontadi A, Tonello M, Salvan E, et al. The clinical significance of autoantibodies directed against prothrombin in primary antiphospholipid syndrome. Clin Chim Acta. 2012;413(9-10):911-3.
31. Sciascia S, Murru V, Sanna G, Roccatello D, Khamashta MA, Bertolaccini ML. Cl inical accuracy for diagnosis of antiphospholipid syndrome in systemic lupus erythematosus: evaluation of 23 possible combinations of antiphospholipid antibody specificities. JTH. 2012;10(12):2512-8.
32. Galli M, Luciani D, Bertolini G, Barbui T. Anti-beta2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome. Blood. 2003;102(8):2717-23. (Pubitemid 37248837)
33. Sciascia S, Sanna G, Murru V, Roccatello D, Khamashta MA, Bertolaccini ML. Anti-prothrombin (aPT) and antiphosphatidylserine/ prothrombin (aPS/PT) antibodies and the risk of thrombosis in the antiphospholipid syndrome. A systematic review. Thromb Haemost. 2013;111(2).
34. Forastiero R, Martinuzzo M, Pombo G, Puente D, Rossi A, Celebrin L, et al. A prospective study of antibodies to beta2-glycoprotein I and prothrombin, and risk of thrombosis. JTH. 2005;3(6):1231-8. (Pubitemid 41725247)
35. Bizzaro N, Ghirardello A, Zampieri S, Iaccarino L, Tozzoli R, Ruffatti A, et al. Anti-prothrombin antibodies predict thrombosis in patients with systemic lupus erythematosus: a 15-year longitudinal study. JTH. 2007;5(6):1158-64. (Pubitemid 46902116)
36. Pengo V, Biasiolo A, Pegoraro C, Cucchini U, Noventa F, Iliceto S. Antibody profiles for the diagnosis of antiphospholipid syndrome. Thromb Haemost. 2005;93(6):1147-52. (Pubitemid 40823521)
37. Zigon P, Cucnik S, Ambrozic A, Kveder T, Semrl SS, Rozman B, et al. Detection of antiphosphatidylserine/prothrombin antibodies and their potential diagnostic value. ClinDev Immunol. 2013;2013: 724592.
38. Tselios K, Sarantopoulos A, Gkougkourellas I, Boura P. The role of anti-phosphatidylserine/prothrombin antibodies in thrombotic manifestations of systemic lupus erythematosus patients. Front Neurol. 2013;4:66.
39. MullenMT, Messe SR, Kasner SE, Sansing L, HusainMR, Norman GL, et al. Anti-phosphatidylserine-prothrombin antibodies are associated with outcome in a TIA cohort. Front Neurol. 2012;3:137.
40. Sanfelippo M, Joshi A, Schwartz S, Meister J, Goldberg J. Antibodies to phosphatidylserine/prothrombin complex in suspected antiphospholipid syndrome in the absence of antibodies to cardiolipin or Beta-2-glycoprotein I. Lupus. 2013;22(13):1349-52.
41. Tsutsumi A, Hayashi T, Chino Y, et al. Significance of antiprothrombin antibodies in patients with systemic lupus erythematosus: clinical evaluation of the antiprothrombin assay and the antiphosphatidylserine/prothrombin assay, and comparison with other antiphospholipid antibody assays. Mod Rheumatol Jpn Rheum Assoc. 2006;16(3):158-64. (Pubitemid 43871691)
42. Bardin N, Alessi MC, Dignat-George F, et al. Does the antiprothrombin antibodies measurement provide additional information in patients with thrombosis? Immunobiology. 2007;212(7): 557-65.
43. Sailer T, Vormittag R, Zoghlami C, et al. The clinical significance of anti-prothrombin antibodies for risk assessment of thromboembolism in patients with lupus anticoagulant. Thromb Res. 2007;120(2):295-302. (Pubitemid 46754423)
44. Hasegawa M, Fujimoto M, Hayakawa I, et al. Antiphosphatidylserine- prothrombin complex antibodies in patients with localized scleroderma. Clin Exp Rheumatol. 2006;24(1):19-24.
45. Tzoulaki I, Liberopoulos G, Ioannidis JP. Assessment of claims of improved prediction beyond the Framingham risk score. JAMA. 2009;302(21):2345- 52.
46. Sciascia S, Cosseddu D, Montaruli B, Kuzenko A, Bertero MT. Risk Scale for the diagnosis of antiphospholipid syndrome. Ann Rheum Dis. 2011;70(8):1517-8.
47. Otomo K, Atsumi T, Amengual O, Fujieda Y, KatoM, Oku K, et al. Efficacy of the antiphospholipid score for the diagnosis of antiphospholipid syndrome and its predictive value for thrombotic events. Arthritis Rheum. 2012;64(2):504-12.
48. Sciascia S, Sanna G, Murru V, Roccatello D, Khamashta MA, Bertolaccini ML. GAPSS: the Global Anti-Phospholipid Syndrome Score. Rheumatology (Oxford). 2013;52(8):1397-403.
49. Sciascia S, Bertolaccini ML, Roccatello D, Khamashta MA. Independent validation of the antiphospholipid score for the diagnosis of antiphospholipid syndrome. Ann Rheum Dis. 2013;72: 142-3.